A. Abel

Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V.

K. Fischbeck, E. Green, J. Vance, 2003, American journal of human genetics.

DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4).

John W Griffin, Imke Puls, K. Fischbeck, 2004, American journal of human genetics.

Dopaminergic deficit in amyotrophic lateral sclerosis assessed with [I-123] IPT single photon emission computed tomography

G. Borasio, K. Tatsch, J. Schwarz, 1998, Journal of neurology, neurosurgery, and psychiatry.

Early onset autosomal dominant spastic paraplegia caused by novel mutations in SPG3A

J. Weissenbach, A. Dürr, A. Brice, 2004, Neurogenetics.

X‐linked Charcot‐Marie‐Tooth Disease and Connexin32

K. Fischbeck, S. Scherer, A. Abel, 1999, Annals of the New York Academy of Sciences.

A gene for autosomal dominant juvenile amyotrophic lateral sclerosis (ALS4 ) localizes to a 500-kb interval on chromosome 9q34

K. Fischbeck, I. Blair, J. Griffin, 2000, Neurogenetics.

Expression of expanded repeat androgen receptor produces neurologic disease in transgenic mice.

J. Walcott, D. Merry, J. Duda, 2001, Human molecular genetics.

The role of the gap junction protein connexin32 in the pathogenesis of X-linked Charcot-Marie-Tooth disease.

K. Fischbeck, R. Balice-Gordon, S. Scherer, 1999, Novartis Foundation symposium.

Androgen receptor mutation in Kennedy's disease.

K. Fischbeck, A. Lieberman, A. Abel, 1999, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

Studies in transgenic mice indicate a loss of connexin32 function in X-linked Charcot-Marie-Tooth disease.

K. Fischbeck, S. Scherer, A. Messing, 1999, Journal of neuropathology and experimental neurology.